E. Yu. Anosova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
E. Yu. Anosova has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- B. I. Yaremin
Moscow Medical University "Reaviz"; N.V. Sklifosovsky Research Institute of Emergency Medicine; N.I. Pirogov Russian National Research Medical University
11 shared publications - Murad Saftarovich Novruzbekov
N.V. Sklifosovsky Research Institute for Emergency Medicine; N.N. Blokhin National Medical Research Center of Oncology
7 shared publications - Bakhtiyar Kazymov
N.V. Sklifosovsky Research Institute of Emergency Medicine; Moscow Medical University "Reaviz
6 shared publications - Kamran Alekberov
N.V. Sklifosovsky Research Institute for Emergency Medicine
4 shared publications - Aslan G. Balkarov
N.V. Sklifosovsky Research Institute for Emergency Medicine ; N.I. Pirogov Russian National Research Medical University (Pirogov University)
3 shared publications - Vladimir Petrovich Gulyaev
N.V. Sklifosovsky Research Institute for Emergency Medicine
3 shared publications
Latest Publications
- Open Access
- 11 December 2025
- Published by IPO Association of Transplantologists in Transplantologiya. The Russian Journal of Transplantation
- Vol. 17 (4) , 479-493
Features of the use of sepsis biomarkers after liver transplantation
Background . Liver transplantation is the only radical treatment for end-stage liver diseases; however, postoperative infectious complications, particularly sepsis, significantly worsen prognosis and increase mortality. Sepsis after liver transplantation develops in 20–40% of recipients and is associated with high mortality (up to 50%), which is caused by immunosuppressive therapy, surgical trauma, and the baseline severity of the patient's condition. Objective . To provide a literature review on sepsis biomarkers after liver transplantation. Material and methods . Analysis of scientific publications in PubMed, Google Scholar, and Medline databases for the period 2015–2025 on the topic of sepsis biomarkers after liver transplantation. Results . The main groups of sepsis biomarkers after liver transplantation were identified and systematized: immunological (T-cell clonality, sTREM-1, presepsin, cytokines), biochemical (procalcitonin, hyaluronic acid, bilirubin, INR), hematological (neutrophil-lymphocyte ratio, platelets), genetic and epigenetic (microRNA, long non-coding RNA). Combined prediction algorithms using clinical scales (SOFA, MELD) and machine learning methods were analyzed. Conclusion . Current data indicates significant prognostic potential of sepsis biomarkers after liver transplantation. The most promising direction is the combination of immunological (T-cell clonality, sTREM-1) and biochemical (PCT, HA) markers, integration of traditional scales (SOFA, MELD) with machine learning algorithms, and the use of genetic and epigenetic markers for a personalized approach. Implementation of these approaches in clinical practice will significantly improve outcomes in liver recipients through early diagnosis of sepsis, timely initiation of therapy, and personalized immunosuppressive treatment.
- 11 December 2025
- Published by IPO Association of Transplantologists in Transplantologiya. The Russian Journal of Transplantation
- Vol. 17 (4) , 479-493
Open AccessFeatures of the use of sepsis biomarkers after liver transplantation
Background . Liver transplantation is the only radical treatment for end-stage liver diseases; however, postoperative infectious complications, particularly sepsis, significantly worsen prognosis and increase mortality. Sepsis after liver transplantation develops in 20–40% of recipients and is associated with high mortality (up to 50%), which is caused by immunosuppressive therapy, surgical trauma, and the baseline severity of the patient's condition. Objective . To provide a literature review on sepsis biomarkers after liver transplantation. Material and methods . Analysis of scientific publications in PubMed, Google Scholar, and Medline databases for the period 2015–2025 on the topic of sepsis biomarkers after liver transplantation. Results . The main groups of sepsis biomarkers after liver transplantation were identified and systematized: immunological (T-cell clonality, sTREM-1, presepsin, cytokines), biochemical (procalcitonin, hyaluronic acid, bilirubin, INR), hematological (neutrophil-lymphocyte ratio, platelets), genetic and epigenetic (microRNA, long non-coding RNA). Combined prediction algorithms using clinical scales (SOFA, MELD) and machine learning methods were analyzed. Conclusion . Current data indicates significant prognostic potential of sepsis biomarkers after liver transplantation. The most promising direction is the combination of immunological (T-cell clonality, sTREM-1) and biochemical (PCT, HA) markers, integration of traditional scales (SOFA, MELD) with machine learning algorithms, and the use of genetic and epigenetic markers for a personalized approach. Implementation of these approaches in clinical practice will significantly improve outcomes in liver recipients through early diagnosis of sepsis, timely initiation of therapy, and personalized immunosuppressive treatment.
- Open Access
- 4 June 2025
- Published by IPO Association of Transplantologists in Transplantologiya. The Russian Journal of Transplantation
- Vol. 17 (2) , 184-199
Arterial complications after liver transplantation: diagnosis, prevention and treatment
Background.Liver transplantation is a life-saving surgery for patients with chronic end-stage liver diseases and individual patients with fulminant liver failure. Over the years, the procedure of the operation has undergone major changes. Recent advances in this field, including improved surgical techniques and the introduction of new immunosuppressive agents, have made it possible to achieve a 5-year survival rate of 87.6%.Objective. To analyze the current scientific literature on arterial complications after liver transplantation, their diagnosis and treatment methods.Material and methods. The scientific articles, reviews and other literature on the topic of arterial complications after liver transplantation for the period from 2015 to the present, published in the databases Pubmed, Google Scholar, Medline, have been studied.Conclusion. Arterial complications remain one of the most dangerous consequences of orthotopic liver transplantation, accompanied by a high risk of graft loss and death. The diagnosis and treatment of these complications is a significant challenge that requires a further search of approaches to improve the efficacy of liver transplantation.
- 4 June 2025
- Published by IPO Association of Transplantologists in Transplantologiya. The Russian Journal of Transplantation
- Vol. 17 (2) , 184-199
Open AccessArterial complications after liver transplantation: diagnosis, prevention and treatment
Background.Liver transplantation is a life-saving surgery for patients with chronic end-stage liver diseases and individual patients with fulminant liver failure. Over the years, the procedure of the operation has undergone major changes. Recent advances in this field, including improved surgical techniques and the introduction of new immunosuppressive agents, have made it possible to achieve a 5-year survival rate of 87.6%.Objective. To analyze the current scientific literature on arterial complications after liver transplantation, their diagnosis and treatment methods.Material and methods. The scientific articles, reviews and other literature on the topic of arterial complications after liver transplantation for the period from 2015 to the present, published in the databases Pubmed, Google Scholar, Medline, have been studied.Conclusion. Arterial complications remain one of the most dangerous consequences of orthotopic liver transplantation, accompanied by a high risk of graft loss and death. The diagnosis and treatment of these complications is a significant challenge that requires a further search of approaches to improve the efficacy of liver transplantation.
- Open Access
- 29 January 2025
- Published by Reaviz Medical University in Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH)
- Vol. 14 (6) , 159-170
Modeling of ischemicreperfusion injury of the liver and kidneys in the experiment: working out the methodology
Introduction. A significant shortage of high-quality donor organs remains one of the most pressing challenges, especially when it comes to extended criteria donors or asystolic donors. The solution to this problem arises at the intersection of surgical skill, advanced biomedical technologies and a deep understanding of the mechanisms of ischemia-reperfusion injury (IRI). Objective. This study was carried out to substantiate and refine the technique of extracorporeal ex-vivo perfusion of a liver graft on an animal model using the Ex-Stream perfusion apparatus for extracorporeal oxygenation according to TU 32.50.21-002-75538036-2020 (RU holder Transbiotek LLC, St. Petersburg, Russia, manufacturer Biosoft-M LLC, Moscow, Russia). Materials and methods. The study was conducted on male pigs weighing 15–30 kg (n = 5). The study is based on the analysis of the results of hypothermic oxygenated perfusion of the liver transplant in a vivarium using a cardiopulmonary bypass apparatus. The study was conducted according to the following protocol: the donor liver was removed from the animal with the formation of a temporary venovenous bypass, pharmaco-cold preservation of the organ using the Ex-Stream apparatus and its subsequent replantation. Results. The following results were obtained in a series of 5 observations. Tissue damage markers (AST, ALT, LDH, GGTP) showed a gradual increase in their level in the perfusate over the course of ischemia. The average values of AST and ALT increased by 2-3 times, LDH - by 1.5-2 times, and GGTP - by 1.2-1.5 times compared to the initial values. The level of malondialdehyde, reflecting oxidative stress, increased by an average of 30–40% by the end of the experiment, while the level of glutathione decreased by 20–25%. Concentrations of proinflammatory cytokines (TNF-α, IL-6, IL-1β) in the perfusate increased 2–4 times compared to baseline values, indicating the development of an inflammatory response. Microscopic examination with hematoxylin and eosin staining revealed signs of ischemic damage to hepatocytes, such as cytoplasmic vacuolization, nuclear pyknosis, and disruption of the beam structure. The degree of damage increased with increasing ischemia time. Mason staining showed a moderate increase in connective tissue in the portal tracts and pericentral zones, indicating initial fibrotic changes. Ultramicroscopic examination (transmission electron microscopy) revealed swelling of mitochondria, disruption of the integrity of their cristae, expansion of the endoplasmic reticulum and formation of autophagosomes in hepatocytes. Oxygen consumption by liver tissue gradually decreased during the experiment, reaching 60-70% of the initial level by the end of the observation. Carbon dioxide production also decreased, but to a lesser extent, amounting to 75-85% of the baseline values. Analysis of the perfusate using a potentiostat-galvanostat IPS showed a gradual decrease in the oxidation-reduction potential, indicating an increase in hypoxia and depletion of antioxidant reserves. The activity of superoxide dismutase and catalase, key antioxidant enzymes, decreased by 30-40% and 20- 30%, respectively, compared with the initial values, indicating a weakening of the antioxidant defense. Conclusion. The obtained results indicate that the developed model using the Ex-Stream device is reproducible and allows for effective study of the state of ischemia-reperfusion injury. This opens up opportunities for conducting a larger and more comprehensive series of experiments, the results of which will be the subject of our further research.
- 29 January 2025
- Published by Reaviz Medical University in Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH)
- Vol. 14 (6) , 159-170
Open AccessModeling of ischemicreperfusion injury of the liver and kidneys in the experiment: working out the methodology
Introduction. A significant shortage of high-quality donor organs remains one of the most pressing challenges, especially when it comes to extended criteria donors or asystolic donors. The solution to this problem arises at the intersection of surgical skill, advanced biomedical technologies and a deep understanding of the mechanisms of ischemia-reperfusion injury (IRI). Objective. This study was carried out to substantiate and refine the technique of extracorporeal ex-vivo perfusion of a liver graft on an animal model using the Ex-Stream perfusion apparatus for extracorporeal oxygenation according to TU 32.50.21-002-75538036-2020 (RU holder Transbiotek LLC, St. Petersburg, Russia, manufacturer Biosoft-M LLC, Moscow, Russia). Materials and methods. The study was conducted on male pigs weighing 15–30 kg (n = 5). The study is based on the analysis of the results of hypothermic oxygenated perfusion of the liver transplant in a vivarium using a cardiopulmonary bypass apparatus. The study was conducted according to the following protocol: the donor liver was removed from the animal with the formation of a temporary venovenous bypass, pharmaco-cold preservation of the organ using the Ex-Stream apparatus and its subsequent replantation. Results. The following results were obtained in a series of 5 observations. Tissue damage markers (AST, ALT, LDH, GGTP) showed a gradual increase in their level in the perfusate over the course of ischemia. The average values of AST and ALT increased by 2-3 times, LDH - by 1.5-2 times, and GGTP - by 1.2-1.5 times compared to the initial values. The level of malondialdehyde, reflecting oxidative stress, increased by an average of 30–40% by the end of the experiment, while the level of glutathione decreased by 20–25%. Concentrations of proinflammatory cytokines (TNF-α, IL-6, IL-1β) in the perfusate increased 2–4 times compared to baseline values, indicating the development of an inflammatory response. Microscopic examination with hematoxylin and eosin staining revealed signs of ischemic damage to hepatocytes, such as cytoplasmic vacuolization, nuclear pyknosis, and disruption of the beam structure. The degree of damage increased with increasing ischemia time. Mason staining showed a moderate increase in connective tissue in the portal tracts and pericentral zones, indicating initial fibrotic changes. Ultramicroscopic examination (transmission electron microscopy) revealed swelling of mitochondria, disruption of the integrity of their cristae, expansion of the endoplasmic reticulum and formation of autophagosomes in hepatocytes. Oxygen consumption by liver tissue gradually decreased during the experiment, reaching 60-70% of the initial level by the end of the observation. Carbon dioxide production also decreased, but to a lesser extent, amounting to 75-85% of the baseline values. Analysis of the perfusate using a potentiostat-galvanostat IPS showed a gradual decrease in the oxidation-reduction potential, indicating an increase in hypoxia and depletion of antioxidant reserves. The activity of superoxide dismutase and catalase, key antioxidant enzymes, decreased by 30-40% and 20- 30%, respectively, compared with the initial values, indicating a weakening of the antioxidant defense. Conclusion. The obtained results indicate that the developed model using the Ex-Stream device is reproducible and allows for effective study of the state of ischemia-reperfusion injury. This opens up opportunities for conducting a larger and more comprehensive series of experiments, the results of which will be the subject of our further research.
- Open Access
- 24 September 2024
- Published by Reaviz Medical University in Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH)
- Vol. 14 (3) , 6-14
The Scientific Journal "Vestnik of the Medical Institute "REAVIZ": History, Challenges, and Perspectives
The paper analyzes the trajectory of development of the scientific periodical "Bulletin of the Medical Institute 'REAVIZ': Rehabilitation, Doctor and Health", examining the key challenges and problematic aspects faced by the journal's editorial board in the course of its current work. Overall, attention is paid to the systematic correction of the main vectors of improving editorial policy in accordance with the best international practices of publishing scientific journals, issues of improving the quality of published materials, deepening the review processes and strict selection of articles for publication, attracting authors from various regions of Russia and foreign countries, analyzing the prospects for developing the practice of publishing accompanying digital data and resources along with textual materials, increasing citation and indexing of the journal in authoritative databases, as well as promoting an open access policy. Based on the results of the analysis, specific plans for the further progressive development of the journal "Bulletin of the Medical Institute 'REAVIZ'" are formulated.
- 24 September 2024
- Published by Reaviz Medical University in Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH)
- Vol. 14 (3) , 6-14
Open AccessThe Scientific Journal "Vestnik of the Medical Institute "REAVIZ": History, Challenges, and Perspectives
The paper analyzes the trajectory of development of the scientific periodical "Bulletin of the Medical Institute 'REAVIZ': Rehabilitation, Doctor and Health", examining the key challenges and problematic aspects faced by the journal's editorial board in the course of its current work. Overall, attention is paid to the systematic correction of the main vectors of improving editorial policy in accordance with the best international practices of publishing scientific journals, issues of improving the quality of published materials, deepening the review processes and strict selection of articles for publication, attracting authors from various regions of Russia and foreign countries, analyzing the prospects for developing the practice of publishing accompanying digital data and resources along with textual materials, increasing citation and indexing of the journal in authoritative databases, as well as promoting an open access policy. Based on the results of the analysis, specific plans for the further progressive development of the journal "Bulletin of the Medical Institute 'REAVIZ'" are formulated.
- Open Access
- 18 September 2024
- Published by Immanuel Kant Baltic Federal University in Surgical Practice
- No. 3,p. 47-59
New perspectives on the role of platelet factors in enhancing wound regeneration
Aim. To analyze the use of biological factors in the stimulation of the wound healing process. In the course of the study, we analysed relevant domestic and foreign literature sources on the given topic.Methods. The literature was reviewed using the key query ‘the role of biological factors in wound healing stimulation’ through the eLIBRARY and PubMed databases.Results. Currently, the range of therapeutic approaches is broad and diverse, incorporating both traditional and experimental methods such as advanced dressings, tissue matrices, growth factors (GFs), cell therapy, and nanotechnology. The wound healing process is regulated by a complex interplay of intercellular, intracellular, and extracellular signalling mechanisms across various phases of healing.Conclusion. The application of platelet-based therapies in different medical fields has shown promising outcomes in certain conditions, such as acute and chronic injuries of bone and cartilage. However, platelet-based preparations have yet to gain widespread clinical use. Several studies have demonstrated the involvement of platelets and related products, such as platelet microparticles (PMPs) and exosomes, in multiple phases of wound healing. The presence of a substantial number of biologically active molecules within platelet granules—exhibiting anti-inflammatory, angiogenic, proliferative, and other properties—renders platelets particularly attractive for use in regenerative medicine, including the stimulation of wound healin
- 18 September 2024
- Published by Immanuel Kant Baltic Federal University in Surgical Practice
- No. 3,p. 47-59
Open AccessNew perspectives on the role of platelet factors in enhancing wound regeneration
Aim. To analyze the use of biological factors in the stimulation of the wound healing process. In the course of the study, we analysed relevant domestic and foreign literature sources on the given topic.Methods. The literature was reviewed using the key query ‘the role of biological factors in wound healing stimulation’ through the eLIBRARY and PubMed databases.Results. Currently, the range of therapeutic approaches is broad and diverse, incorporating both traditional and experimental methods such as advanced dressings, tissue matrices, growth factors (GFs), cell therapy, and nanotechnology. The wound healing process is regulated by a complex interplay of intercellular, intracellular, and extracellular signalling mechanisms across various phases of healing.Conclusion. The application of platelet-based therapies in different medical fields has shown promising outcomes in certain conditions, such as acute and chronic injuries of bone and cartilage. However, platelet-based preparations have yet to gain widespread clinical use. Several studies have demonstrated the involvement of platelets and related products, such as platelet microparticles (PMPs) and exosomes, in multiple phases of wound healing. The presence of a substantial number of biologically active molecules within platelet granules—exhibiting anti-inflammatory, angiogenic, proliferative, and other properties—renders platelets particularly attractive for use in regenerative medicine, including the stimulation of wound healin
- Open Access
- 22 July 2024
- Published by Reaviz Medical University in Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH)
- Vol. 14 (3) , 156-160
Technological Checklist for Kidney and Liver Transplantation in a Multidisciplinary Hospital. Clinical Protocol
This clinical protocol delineates the technological requirements for performing kidney and liver transplantation procedures in a multidisciplinary hospital setting. The protocol has been developed based on clinical guidelines from leading international societies and has been approved by the Samara Regional Branch of the Interregional Public Organization "Society of Transplantologists" (Protocol No. 11 dated July 1, 2024). It is recommended for use in assessing a hospital's readiness to implement transplantation programs. The technologies specified in the protocol may be implemented either through the hospital's own resources or via agreements with other healthcare institutions or through outsourcing arrangements.
- 22 July 2024
- Published by Reaviz Medical University in Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH)
- Vol. 14 (3) , 156-160
Open AccessTechnological Checklist for Kidney and Liver Transplantation in a Multidisciplinary Hospital. Clinical Protocol
This clinical protocol delineates the technological requirements for performing kidney and liver transplantation procedures in a multidisciplinary hospital setting. The protocol has been developed based on clinical guidelines from leading international societies and has been approved by the Samara Regional Branch of the Interregional Public Organization "Society of Transplantologists" (Protocol No. 11 dated July 1, 2024). It is recommended for use in assessing a hospital's readiness to implement transplantation programs. The technologies specified in the protocol may be implemented either through the hospital's own resources or via agreements with other healthcare institutions or through outsourcing arrangements.
- Open Access
- 12 July 2024
- Published by Reaviz Medical University in Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH)
- Vol. 14 (3) , 111-120
The role of immunotolerance in immunosuppressive therapy after liver transplantation
Relevance. Some achievements related to liver transplantation in the field of infectious complications, rejection treatment and surgical tactics have also contributed to improving patient survival. Nevertheless, it is true that the huge progress made in the field of transplantation is mainly due to the emergence of safe and effective immunosuppressive drugs. But complications from immunosuppressive drugs are still a significant problem and the ability to give up immunosuppressants altogether or significantly reduce the dose will help solve it. Aim: to present a review of the literature and to analyze the main aspects of immunotolerance in immunosuppressive therapy after liver transplantation. Materials and methods: Foreign and Russian literature on the topic of immunotolerance and immunosuppressive therapy was used. The search for literary data was carried out in international databases (PubMed/MedLine, ResearchGate), as well as in the scientific electronic library of Russia (eLIBRARY.RU ) for the period 2019– 2024. Conclusion. Undoubtedly, the rejection of immunosuppressive therapy is a brilliant prospect for recipients not only of the liver, but also of other donor organs, therefore, with the future development of interdisciplinary and multifactorial research, the use of various new experimental methods may provide more opportunities and theoretical guidance to find a way to achieve tolerance in liver transplantation.
- 12 July 2024
- Published by Reaviz Medical University in Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH)
- Vol. 14 (3) , 111-120
Open AccessThe role of immunotolerance in immunosuppressive therapy after liver transplantation
Relevance. Some achievements related to liver transplantation in the field of infectious complications, rejection treatment and surgical tactics have also contributed to improving patient survival. Nevertheless, it is true that the huge progress made in the field of transplantation is mainly due to the emergence of safe and effective immunosuppressive drugs. But complications from immunosuppressive drugs are still a significant problem and the ability to give up immunosuppressants altogether or significantly reduce the dose will help solve it. Aim: to present a review of the literature and to analyze the main aspects of immunotolerance in immunosuppressive therapy after liver transplantation. Materials and methods: Foreign and Russian literature on the topic of immunotolerance and immunosuppressive therapy was used. The search for literary data was carried out in international databases (PubMed/MedLine, ResearchGate), as well as in the scientific electronic library of Russia (eLIBRARY.RU ) for the period 2019– 2024. Conclusion. Undoubtedly, the rejection of immunosuppressive therapy is a brilliant prospect for recipients not only of the liver, but also of other donor organs, therefore, with the future development of interdisciplinary and multifactorial research, the use of various new experimental methods may provide more opportunities and theoretical guidance to find a way to achieve tolerance in liver transplantation.
- Open Access
- 25 June 2024
- Published by IPO Association of Transplantologists in Transplantologiya. The Russian Journal of Transplantation
- Vol. 16 (2) , 244-259
Understudied targets of the ischemia-reperfusion injury pathogenesis in liver transplantation
Background. Liver transplantation is currently the most effective method to treat diseases with end-stage liver failure. Complications are most often associated with the initially severe patient condition, imperfect organ preservation methods, the surgical management per se, and immune system incompetence. The most common complications of transplantation include ischemic reperfusion injury, which occurs to some or another extent in each transplanted organ and worsens the course of the postoperative period. The process is based on complex pathophysiological mechanisms of cell damage due to ischemia and inflammation caused by reperfusion.Objective. To summarize current data on the mechanisms of the ischemic reperfusion injury development in liver transplantation and to find the ways to reduce adverse effects.Material and methods. The analysis of data from foreign and homeland experimental and clinical studies on the pathogenesis of ischemic reperfusion injury in liver transplantation has been performed. The search for literature data was carried out in international databases (PubMed/MedLine, ResearchGate, as well as in the scientific electronic library of Russia (eLibrary.RU) for the period from 2020-2024.Conclusion. The analyzed publications have provided various algorithms for the preservation of donor organs, including those using machine perfusion.
- 25 June 2024
- Published by IPO Association of Transplantologists in Transplantologiya. The Russian Journal of Transplantation
- Vol. 16 (2) , 244-259
Open AccessUnderstudied targets of the ischemia-reperfusion injury pathogenesis in liver transplantation
Background. Liver transplantation is currently the most effective method to treat diseases with end-stage liver failure. Complications are most often associated with the initially severe patient condition, imperfect organ preservation methods, the surgical management per se, and immune system incompetence. The most common complications of transplantation include ischemic reperfusion injury, which occurs to some or another extent in each transplanted organ and worsens the course of the postoperative period. The process is based on complex pathophysiological mechanisms of cell damage due to ischemia and inflammation caused by reperfusion.Objective. To summarize current data on the mechanisms of the ischemic reperfusion injury development in liver transplantation and to find the ways to reduce adverse effects.Material and methods. The analysis of data from foreign and homeland experimental and clinical studies on the pathogenesis of ischemic reperfusion injury in liver transplantation has been performed. The search for literature data was carried out in international databases (PubMed/MedLine, ResearchGate, as well as in the scientific electronic library of Russia (eLibrary.RU) for the period from 2020-2024.Conclusion. The analyzed publications have provided various algorithms for the preservation of donor organs, including those using machine perfusion.
- Open Access
- 12 April 2024
- Published by Reaviz Medical University in Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH)
- Vol. 14 (1) , 6-22
Ethical Views on the Issue of Organ Donation and Transplantation in Catholic Doctrine
In countries in Europe and America with a predominance of Christians in the population, there is a higher level of organ donation. Although the issue of post mortem donation is not mentioned in the Holy Scriptures, the idea of selfless sacrifice is entirely in keeping with the Christian spirit. The Roman Catholic Church was the first to recognize organ donation and transplantation as morally acceptable and indicated that it encourages organ donation.The purpose of the work was to analyze the views set forth in the official documents of the Roman Catholic Church on the issues of ethics in organ donation and transplantation.Materials and methods. The provisions of the Catechism of the Catholic Church, the Epistles of the Popes of Rome, the Code of Canon Law and other ethical documents on the acceptability of the technology of organ transplantation and postmortem donation, the principle of the presumption of consent, the legitimacy of the declaration of brain death, the condemnation of organ trafficking, the inadmissibility of discrimination in the allocation of organs, the admissibility of transplantation from living donors, donation from infants with anencephaly, xenotransplantation are analyzed.Conclusion. The presented work testifies to the fact that the Catholic position on organ donation and transplantation is well and deeply developed, based on respect for the dignity of a person and his right to choose, the encouragement of the voluntary act of donating one's organs as a gift extending beyond the border of life and death.
- 12 April 2024
- Published by Reaviz Medical University in Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH)
- Vol. 14 (1) , 6-22
Open AccessEthical Views on the Issue of Organ Donation and Transplantation in Catholic Doctrine
In countries in Europe and America with a predominance of Christians in the population, there is a higher level of organ donation. Although the issue of post mortem donation is not mentioned in the Holy Scriptures, the idea of selfless sacrifice is entirely in keeping with the Christian spirit. The Roman Catholic Church was the first to recognize organ donation and transplantation as morally acceptable and indicated that it encourages organ donation.The purpose of the work was to analyze the views set forth in the official documents of the Roman Catholic Church on the issues of ethics in organ donation and transplantation.Materials and methods. The provisions of the Catechism of the Catholic Church, the Epistles of the Popes of Rome, the Code of Canon Law and other ethical documents on the acceptability of the technology of organ transplantation and postmortem donation, the principle of the presumption of consent, the legitimacy of the declaration of brain death, the condemnation of organ trafficking, the inadmissibility of discrimination in the allocation of organs, the admissibility of transplantation from living donors, donation from infants with anencephaly, xenotransplantation are analyzed.Conclusion. The presented work testifies to the fact that the Catholic position on organ donation and transplantation is well and deeply developed, based on respect for the dignity of a person and his right to choose, the encouragement of the voluntary act of donating one's organs as a gift extending beyond the border of life and death.
- Open Access
- 22 March 2024
- Published by IPO Association of Transplantologists in Transplantologiya. The Russian Journal of Transplantation
- Vol. 16 (1) , 116-134
Therapeutic agents for machine perfusion of donor organs
Background. The urgency of the unmet need for transplant care dictates the necessity to use organs from suboptimal donors. Machine perfusion, which is actively developing at the present time, is designated to solve this problem. The literature presents novel technologies of ex vivo and in vivo machine perfusion of donor organs, which make it possible to improve their functions and perform a successful transplant. The most promising areas of research both in animals and in humans may be identified by reviewing the literature sources on this subject.The aim was to analyze the world experience of using therapeutic agents in machine perfusion of donor organsMaterial and methods: sources from 2015 to 2023 found in PubMed, Google Scholar, eLibrary databasesConclusion. The rapid progress in lung, liver and kidney transplantation has made it possible to use grafts from asystolic donors for patients in urgent need of donor organs. In turn, these advances have also prompted the study of potential therapeutic agents that can be used during perfusion.
- 22 March 2024
- Published by IPO Association of Transplantologists in Transplantologiya. The Russian Journal of Transplantation
- Vol. 16 (1) , 116-134
Open AccessTherapeutic agents for machine perfusion of donor organs
Background. The urgency of the unmet need for transplant care dictates the necessity to use organs from suboptimal donors. Machine perfusion, which is actively developing at the present time, is designated to solve this problem. The literature presents novel technologies of ex vivo and in vivo machine perfusion of donor organs, which make it possible to improve their functions and perform a successful transplant. The most promising areas of research both in animals and in humans may be identified by reviewing the literature sources on this subject.The aim was to analyze the world experience of using therapeutic agents in machine perfusion of donor organsMaterial and methods: sources from 2015 to 2023 found in PubMed, Google Scholar, eLibrary databasesConclusion. The rapid progress in lung, liver and kidney transplantation has made it possible to use grafts from asystolic donors for patients in urgent need of donor organs. In turn, these advances have also prompted the study of potential therapeutic agents that can be used during perfusion.